BluTest Laboratories Ltd

www.blutest.com

Microbiology Contract Research Organization specializing in microbiology outsourcing, virus screening, antimicrobial product development, biocide efficacy testing, bacteria, mycobacteria, bacterial endospores, virology, biofilms, disinfection, clean room and environmental monitoring.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MedTech

ARBOR BIOTECHNOLOGIES ENTERS INTO AGREEMENT WITH ACUITAS THERAPEUTICS FOR LIPID NANOPARTICLE DELIVERY SYSTEM FOR USE IN RARE LIVER DISEASES

Arbor Biotechnologies Inc | August 29, 2022

news image

Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that it has entered into an agreement with Acuitas Therapeutics, a leader in the development of lipid nanoparticles. As part of the agreement, the companies will combine the optimized delivery of Acuitas' highly validated LNP technology with Arbor’s differentiated, proprietary CRISPR gene editing technology designed for use in vivo in patien...

Read More

Industrial Impact

NOVALIQ SUBMITS NEW DRUG APPLICATION SEEKING APPROVAL FOR FIRST-OF-A-KIND DRY EYE DISEASE TREATMENT CYCLASOL®

Novaliq GmbH | August 10, 2022

news image

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, announced the submission of a New Drug Application to the U.S. Food and Drug Administration seeking approval for CyclASol® a proposed novel treatment for the signs and symptoms of dry eye disease. CyclASol® has demonstrated in two pivotal studies fast onset of therapeutic effect in the indication, clinical meaningful improveme...

Read More

Cell and Gene Therapy

ELEVATEBIO AND THE UNIVERSITY OF PITTSBURGH ANNOUNCE CREATION OF PITT BIOFORGE BIOMANUFACTURING CENTER AT HAZELWOOD GREEN

ElevateBio | August 26, 2022

news image

ElevateBio, LLC and the University of Pittsburgh announced that they have entered into a long-term strategic partnership to accelerate the development of highly innovative cell and gene therapies. Through this agreement, ElevateBio will locate one of its next BaseCamp process development and Good Manufacturing Practice manufacturing facilities in Pittsburgh, fully equipped with its enabling technologies, including gene editing, induced pluripotent stem cell and cell, vector, and protein engineer...

Read More

Industrial Impact

SENDA BIOSCIENCES BOLSTERS EXECUTIVE LEADERSHIP TEAM

Senda Biosciences | October 20, 2022

news image

Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the appointments of Lori Rudolph-Owen, Ph.D., as Chief Operating Officer, and Barbara Bispham, J.D., as SVP, General Counsel. "We're delighted to add Lori and Barbara to the Senda leadership team as we work to build a world-class organization. Each of these seasoned executives brings the skills and experience necessary to h...

Read More
news image

MedTech

ARBOR BIOTECHNOLOGIES ENTERS INTO AGREEMENT WITH ACUITAS THERAPEUTICS FOR LIPID NANOPARTICLE DELIVERY SYSTEM FOR USE IN RARE LIVER DISEASES

Arbor Biotechnologies Inc | August 29, 2022

Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that it has entered into an agreement with Acuitas Therapeutics, a leader in the development of lipid nanoparticles. As part of the agreement, the companies will combine the optimized delivery of Acuitas' highly validated LNP technology with Arbor’s differentiated, proprietary CRISPR gene editing technology designed for use in vivo in patien...

Read More
news image

Industrial Impact

NOVALIQ SUBMITS NEW DRUG APPLICATION SEEKING APPROVAL FOR FIRST-OF-A-KIND DRY EYE DISEASE TREATMENT CYCLASOL®

Novaliq GmbH | August 10, 2022

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, announced the submission of a New Drug Application to the U.S. Food and Drug Administration seeking approval for CyclASol® a proposed novel treatment for the signs and symptoms of dry eye disease. CyclASol® has demonstrated in two pivotal studies fast onset of therapeutic effect in the indication, clinical meaningful improveme...

Read More
news image

Cell and Gene Therapy

ELEVATEBIO AND THE UNIVERSITY OF PITTSBURGH ANNOUNCE CREATION OF PITT BIOFORGE BIOMANUFACTURING CENTER AT HAZELWOOD GREEN

ElevateBio | August 26, 2022

ElevateBio, LLC and the University of Pittsburgh announced that they have entered into a long-term strategic partnership to accelerate the development of highly innovative cell and gene therapies. Through this agreement, ElevateBio will locate one of its next BaseCamp process development and Good Manufacturing Practice manufacturing facilities in Pittsburgh, fully equipped with its enabling technologies, including gene editing, induced pluripotent stem cell and cell, vector, and protein engineer...

Read More
news image

Industrial Impact

SENDA BIOSCIENCES BOLSTERS EXECUTIVE LEADERSHIP TEAM

Senda Biosciences | October 20, 2022

Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the appointments of Lori Rudolph-Owen, Ph.D., as Chief Operating Officer, and Barbara Bispham, J.D., as SVP, General Counsel. "We're delighted to add Lori and Barbara to the Senda leadership team as we work to build a world-class organization. Each of these seasoned executives brings the skills and experience necessary to h...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us